Platinum Investment Management LTD Gilead Sciences, Inc. Transaction History

Platinum Investment Management LTD

$2.16 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $3.17 Million - $3.62 Million	-41,764 Reduced 5.66%	695,505 $53.6 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $5.16 Million - $5.87 Million	-66,690 Reduced 8.3%	737,269 $61.2 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $443,843 - $637,205	7,122 Added 0.89%	803,959 $69 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $9.94 Million - $11.4 Million	-166,910 Reduced 17.32%	796,837 $49.2 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $7.26 Million - $8.18 Million	-125,822 Reduced 11.55%	963,747 $59.6 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $1.78 Million - $2.23 Million	-30,763 Reduced 2.75%	1,089,569 $64.8 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $22 Million - $24.9 Million	-338,398 Reduced 23.2%	1,120,332 $81.3 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $4.08 Million - $4.4 Million	-60,303 Reduced 3.97%	1,458,730 $102 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $9.54 Million - $10.4 Million	-150,311 Reduced 9.0%	1,519,033 $105 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $5.38 Million - $6.13 Million	89,588 Added 5.67%	1,669,344 $108 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.72 Million - $3.1 Million	-48,002 Reduced 2.95%	1,579,756 $92 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $886,415 - $1.11 Million	-14,274 Reduced 0.87%	1,627,758 $103 Million
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $11.8 Million - $13.7 Million	-162,880 Reduced 9.02%	1,642,032 $126 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $59.6 Million - $76.4 Million	-951,771 Reduced 34.53%	1,804,912 $135 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $45.3 Million - $49.8 Million	735,216 Added 36.37%	2,756,683 $179 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $342,179 - $377,706	5,474 Added 0.27%	2,021,467 $128 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $187,899 - $210,707	-3,037 Reduced 0.15%	2,015,993 $136 Million
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $73.1 Million - $81 Million	-1,025,900 Reduced 33.69%	2,019,030 $156 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $10.3 Million - $12.1 Million	145,300 Added 5.01%	3,044,930 $218 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $728,311 - $863,247	10,100 Added 0.35%	2,899,630 $235 Million
Q2 2017 Aug 15, 2017	BUY	N/A	2,889,530	2,889,530 $205 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account